Crossmark

Real-world status of continuous positive airway pressure (CPAP) persistence in patients with sleep apnea syndrome (SAS): a retrospective longitudinal study of administrative claims data in Japan

Crossref DOI link: https://doi.org/10.1007/s11325-025-03417-w

Published Online: 2025-07-17

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Hiroyuki

Yoshida, Shiori

Nakajima, Akihiro

Koto, Ruriko

Nakayama, Hideaki https://orcid.org/0000-0001-5405-9073
Funding

Funding for this research was provided by:

Teijin Pharma Limited (Teijin Pharma Limited)
License Information

Text and Data Mining valid from 2025-07-17

Version of Record valid from 2025-07-17
More Information

Article History

Received: 11 July 2024

Revised: 25 June 2025

Accepted: 9 July 2025

First Online: 17 July 2025

Change Date: 24 December 2025

Change Type: Update

Change Details: In the original version of this article, open access license was not correct. This has been updated to CC BY accordingly.

Declarations

:

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: Because the data used in this study came from a large health insurance claims database and were fully anonymized, there was no need for informed consent from individual patients or approval from the Institutional Review Board (IRB).

: Hiroyuki Takahashi, Shiori Yoshida, Akihiro Nakajima, and Ruriko Koto are employees of Teijin Pharma Limited. Shiori Yoshida, Akihiro Nakajima and Ruriko Koto hold stock in Teijin Limited. Hideaki Nakayama has received consulting fees from Teijin Pharma Limited and is affiliated with a department of somnology that receives support from Philips Japan and Koike Medical Co., LTD.

Document is current

Any future updates will be listed below